JOURNAL ARTICLE
REVIEW
Add like
Add dislike
Add to saved papers

ACR Appropriateness Criteria on treatment of acute nonvariceal gastrointestinal tract bleeding.

Acute upper gastrointestinal (UGI) tract bleeding is best initially investigated and treated with endoscopy. For patients who fail therapeutic endoscopy, both surgery and transcatheter arteriography and intervention (TAI) are equally effective. Transcatheter arteriography and intervention should be considered as a treatment option in patients with UGI bleeding, particularly those at high risk for surgery. Transcatheter arteriography and intervention for UGI bleeding has a low rate of major complications, and prolonged clinical success is seen in at least 65% of patients. Transcatheter arteriography and intervention is the best method of treatment for bleeding occurring into the biliary tree or pancreatic duct. In patients with acute lower gastrointestinal (LGI) tract bleeding who are hemodynamically stable, either colonoscopy or nuclear medicine scans can be used for diagnosis. Colonoscopy will identify the site of bleeding more frequently than other methods and can provide effective treatment. The use of emergent TAI is most appropriate for patients with massive LGI bleeding, because contrast extravasation is more likely to be seen on diagnostic arteriography, and this can then guide therapeutic embolization. Transcatheter arteriography and intervention may successfully stop bleeding in 40% to 85% of patients. Major complications from TAI are uncommon, but the risk for rebleeding is quite high, particularly when LGI bleeding originates from the jejunum, ileum, or cecum. Transcatheter arteriography and intervention is most effective for the treatment of bleeding from colonic diverticulitis and for bleeding occurring distal to the cecum. The choice of colonoscopy, TAI, or surgery for hemodynamically unstable patients with acute LGI bleeding will depend on institutional expertise and whether the site of bleeding has been localized.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app